CLINICAL_TRIALS
trial_result
· 2012-08-15
Clinical Trial Update: Symbicort Rapihaler Therapeutic Equivalence Study [Phase 3]
Summary
A Phase 3 study evaluating the therapeutic equivalence of Symbicort Rapihaler in bronchial asthma has completed, with results posted in 2012.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: AstraZeneca | Conditions: Bronchial Asthma | Phase 3 | Status: COMPLETED | Results posted: 2012-08-15